Cerebras Systems is having its best day since its IPO, and Wall Street is finally making its case. Shares surged 19% Monday, the largest single-day gain in the company’s brief public history, as a wave of analyst coverage initiations argued the stock has become attractive after pulling back sharply from its post-IPO highs above $300. Here is what the analysts are saying and why the OpenAI concentration risk that spooked early investors may be less concerning than it initially appeared.
Mizuho initiated coverage with an Outperform rating and a $300 price target, arguing that Cerebras is well-positioned as the industry leader in fast inference at a time when agentic AI solutions are driving demand for speed above all else. Wedbush initiated with a Buy rating and a $270 price target, based on 40 times its 2028 earnings estimate plus net cash, describing the setup as asymmetric and upside-skewed given Cerebras’ differentiated architecture and a contracted revenue base that has expanded beyond a single customer.
The differentiation story centers on chip design. Cerebras builds unusually large processors made from an entire silicon wafer, a format that excels at running AI models at high speed while bypassing much of the complex networking and packaging required to connect thousands of conventional chips from Nvidia and other manufacturers. That architecture makes Cerebras particularly effective for inference workloads, the part of the AI pipeline where models respond to users in real time.
The primary concern around Cerebras has been customer concentration. At the end of 2025, the majority of its $24.6 billion backlog came from a single cloud agreement with OpenAI. A subsequent deal with Amazon Web Services broadens that customer base and gives analysts greater confidence that the revenue pipeline is not entirely dependent on a single relationship.
Cerebras shares remain well below the $300-plus levels reached immediately after its May IPO despite Monday’s recovery.
